News After more encouraging data, Ablynx to file first drug with ... New trial data will be included in US and EU filings
Partner Content Partner Content “SPARKing" New Antibiotic Drug Discovery “SPARKing" New Antibiotic Drug Discovery
News J&J rumoured to be sizing up $12bn Genmab acquisition Speculation mounts that J&J will bid for R&D partner
News Can Spark make a profit on its groundbreaking gene therapy? Spark Therapeutics is on the cusp of gaining the first ever approval for a gene therapy from the FDA, a groundbreaking treatment which restores vision to children and adults with a rare inh
News Shire CEO backs outcomes-based deals in rare diseases Strategy could help make rare disease drugs affordable
News Ultragenyx to slash costs after Angelman trial failure Ultragenyx's therapy for the rare genetic disorder Angelman syndrome, apazunersen, has flunked a late-stage trial, crashing its share price.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
